Casebia Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Casebia Therapeutics is a biotechnology research company created by Bayer and CRISPR Therapeutics to discover, develop, and commercialize new therapeutics for blood disorders, blindness, and congenital heart disease. The venture combines Bayer's protein engineering capabilities with CRISPR Therapeutics' gene-editing technology and intellectual property to pursue systemic in vivo gene editing. It aims to advance delivery systems that enable therapeutic editing to occur within the body. Based in Cambridge, Massachusetts, the company is mid-sized and operates within the biotechnology sector. The arrangement is described as the first long-term strategic partnership of its kind to invest in target delivery systems for systemic in vivo gene editing. This collaboration underpins Casebia's focus on bringing gene-editing therapeutics for the listed conditions toward development and potential clinical application.